Mørk, Arne
Otsuka (Japan) · Lundbeck (Denmark) · Otsuka (United States) · Lundbeck (United States) · Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
4 papers on CoChat
Most cited papers
- Verified
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry
Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior
Cited by 606
- Verified
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Maeda, K., Sugino, H., Akazawa, H., Amada, N., Shimada, J., Futamura, T., Yamashita, H., Ito, N., McQuade, R. D., Mørk, A., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics
Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment
Cited by 372
- Verified
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Mørk, A., Pehrson, A., Brennum, L. T., Nielsen, S. M., Zhong, H., Lassen, A. B., Miller, S., Westrich, L., Boyle, N. J., Sánchez, C., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics
Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior
Cited by 271
- Verified
Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., et al. (2004) · Neuropsychopharmacology
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 157
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free